Vital3D, a Lithuanian startup, is advancing towards bioprinted organs with its initial product, a wound patch for dogs, designed to facilitate skin regeneration. Using a specialized laser system, the company creates functional tissue constructs that could potentially lead to organ transplants in about a decade. CEO Vidmantas Šakalys, motivated by personal loss, stresses the importance of developing commercially viable products first. The VitalHeal patch is engineered to reduce healing times severely, lower infection risks, and streamline veterinary care, marking a significant step toward future human applications.
Vital3D is pioneering the use of bioprinting technology to create a wound patch for dogs, aiming to realize organ transplants in the next decade.
CEO Vidmantas Šakalys emphasizes the necessity of starting with simpler products before tackling the complex challenge of bioprinting human organs.
Collection
[
|
...
]